Share on StockTwits
 

Perrigo (NASDAQ:PRGO) announced a quarterly dividend on Wednesday, January 29th, Analyst RN reports. Investors of record on Friday, February 28th will be paid a dividend of 0.105 per share on Tuesday, March 18th. This represents a $0.42 annualized dividend and a dividend yield of 0.27%.

PRGO has been the subject of a number of recent research reports. Analysts at Argus raised their price target on shares of Perrigo from $160.00 to $175.00 in a research note to investors on Thursday, January 16th. They now have a “buy” rating on the stock. On a related note, analysts at Bank of America Corp. upgraded shares of Perrigo from a “neutral” rating to a “buy” rating in a research note to investors on Tuesday, January 7th. They now have a $171.00 price target on the stock, up previously from $162.00. Finally, analysts at RBC Capital initiated coverage on shares of Perrigo in a research note to investors on Monday, January 6th. They set a “top pick” rating and a $187.00 price target on the stock. Three analysts have rated the stock with a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $151.98.

Perrigo (NASDAQ:PRGO) traded down 1.60% on Wednesday, hitting $154.53. 677,517 shares of the company’s stock traded hands. Perrigo has a 1-year low of $98.86 and a 1-year high of $162.35. The stock’s 50-day moving average is $154.6 and its 200-day moving average is $137.. The company has a market cap of $14.572 billion and a price-to-earnings ratio of 33.13.

In other Perrigo news, Chairman Joseph Papa sold 5,000 shares of the company’s stock on the open market in a transaction dated Thursday, January 16th. The stock was sold at an average price of $157.59, for a total value of $787,950.00. Following the completion of the sale, the chairman now directly owns 96,655 shares of the company’s stock, valued at approximately $15,231,861. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Perrigo Company is a global healthcare supplier that develops, manufactures and distributes over-the-counter (NASDAQ:PRGO) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products and active pharmaceutical ingredients (API).

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.